ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, C J
Right arrow Articles by Edwards, M S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, C J
Right arrow Articles by Edwards, M S
Archives of Disease in Childhood 2003;88:375-378
© 2003 BMJ Publishing Group & Royal College of Paediatrics and Child Health

REVIEW

Group B streptococcal conjugate vaccines

C J Baker, M S Edwards

Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA

Correspondence to:
Correspondence to:
Dr M S Edwards, Baylor College of Medicine, One Baylor Plaza, Room 302A, Houston, Texas 77030, USA;
morvene{at}bcm.tmc.edu


ABSTRACT
Linkage of bacterial capsular polysaccharides to proteins to create conjugate vaccines has had a dramatic impact on the health of children. Although unconjugated polysaccharides are poorly immunogenic in infants and some older children and adults, their covalent coupling with proteins stimulates T cell dependent antigenic recognition that profoundly enhances immunogenicity. In the decade since the introduction and widespread use of Haemophilus influenzae type b polysaccharide conjugate vaccines in the United States, invasive H influenzae infections have become a rarity in childhood.1 Similarly, the conjugation of polysaccharides of Streptococcus pneumoniae to a derivative of diphtheria toxoid and the addition of pneumococcal conjugate vaccine to infant immunisation schedules carries with it promise for a similar decline in the incidence of invasive pneumococcal disease in paediatric patients.2

Keywords: vaccine; streptococcus

Abbreviations: CPS, capsular polysaccharide; GBS, group B streptococcus; GMC, geometric mean concentration; IAP, intrapartum antibiotic prophylaxis; TT, tetanus toxoid




This article has been cited by other articles:


Home page
 CVIHome page
H.-H. Yang, S. J. Mascuch, L. C. Madoff, and L. C. Paoletti
Recombinant Group B Streptococcus Alpha-Like Protein 3 Is an Effective Immunogen and Carrier Protein
Clin. Vaccine Immunol., July 1, 2008; 15(7): 1035 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H.-H. Yang, L. C. Madoff, H.-K. Guttormsen, Y.-D. Liu, and L. C. Paoletti
Recombinant Group B Streptococcus Beta C Protein and a Variant with the Deletion of Its Immunoglobulin A-Binding Site Are Protective Mouse Maternal Vaccines and Effective Carriers in Conjugate Vaccines
Infect. Immun., July 1, 2007; 75(7): 3455 - 3461.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. V. Ramaswamy, P. Ferrieri, A. E. Flores, and L. C. Paoletti
Molecular characterization of nontypeable group B streptococcus.
J. Clin. Microbiol., July 1, 2006; 44(7): 2398 - 2403.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. D. Manning, D. W. Lacher, H. D. Davies, B. Foxman, and T. S. Whittam
DNA Polymorphism and Molecular Subtyping of the Capsular Gene Cluster of Group B Streptococcus
J. Clin. Microbiol., December 1, 2005; 43(12): 6113 - 6116.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. Seepersaud, S. B. Hanniffy, P. Mayne, P. Sizer, R. Le Page, and J. M. Wells
Characterization of a Novel Leucine-Rich Repeat Protein Antigen from Group B Streptococci That Elicits Protective Immunity
Infect. Immun., March 1, 2005; 73(3): 1671 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
G. Lindahl, M. Stalhammar-Carlemalm, and T. Areschoug
Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens
Clin. Microbiol. Rev., January 1, 2005; 18(1): 102 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
R. S. Gibbs, S. Schrag, and A. Schuchat
Perinatal Infections Due to Group B Streptococci
Obstet. Gynecol., November 1, 2004; 104(5): 1062 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 Br Med BullHome page
A. Finn
Bacterial polysaccharide-protein conjugate vaccines
Br. Med. Bull., August 31, 2004; 70(1): 1 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. L. Lewis, V. Nizet, and A. Varki
Discovery and characterization of sialic acid O-acetylation in group B Streptococcus
PNAS, July 27, 2004; 101(30): 11123 - 11128.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
D. Kaufman and K. D. Fairchild
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Clin. Microbiol. Rev., July 1, 2004; 17(3): 638 - 680.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
R. Creti, F. Fabretti, G. Orefici, and C. von Hunolstein
Multiplex PCR Assay for Direct Identification of Group B Streptococcal Alpha-Protein-Like Protein Genes
J. Clin. Microbiol., March 1, 2004; 42(3): 1326 - 1329.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health